n,n-dimethylarginine has been researched along with casein kinase ii in 1 studies
| Studies (n,n-dimethylarginine) | Trials (n,n-dimethylarginine) | Recent Studies (post-2010) (n,n-dimethylarginine) | Studies (casein kinase ii) | Trials (casein kinase ii) | Recent Studies (post-2010) (casein kinase ii) |
|---|---|---|---|---|---|
| 2,216 | 228 | 1,221 | 3,268 | 5 | 1,299 |
| Protein | Taxonomy | n,n-dimethylarginine (IC50) | casein kinase ii (IC50) |
|---|---|---|---|
| Serine/threonine-protein kinase Sgk1 | Homo sapiens (human) | 3.57 | |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | Homo sapiens (human) | 0.484 | |
| Casein kinase II subunit alpha | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha' | Homo sapiens (human) | 2.23 | |
| Cyclin-A2 | Homo sapiens (human) | 2.38 | |
| Cyclin-dependent kinase 2 | Homo sapiens (human) | 2.38 | |
| Casein kinase II subunit beta | Homo sapiens (human) | 2.23 | |
| Casein kinase II subunit beta | Rattus norvegicus (Norway rat) | 0.14 | |
| Casein kinase II subunit alpha | Homo sapiens (human) | 2.23 | |
| Cyclin-A1 | Homo sapiens (human) | 2.38 | |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | Homo sapiens (human) | 0.26 | |
| Casein kinase II subunit alpha 3 | Homo sapiens (human) | 0.14 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duggan, E; Kelleher, D; McGovern, E; McManus, R; O'Dwyer, MJ; Ryan, AW; Ryan, R; Ryan, T; Thornton, J | 1 |
1 other study(ies) available for n,n-dimethylarginine and casein kinase ii
| Article | Year |
|---|---|
Gene polymorphism and requirement for vasopressor infusion after cardiac surgery.
Topics: Adaptor Proteins, Signal Transducing; Aged; Alleles; Amidohydrolases; Arginine; Cardiac Surgical Procedures; Casein Kinase II; Cohort Studies; Comorbidity; Elective Surgical Procedures; Epinephrine; Female; Genetic Predisposition to Disease; Genotype; Histocompatibility Antigens Class II; Humans; Inflammation; Lymphotoxin-alpha; Major Histocompatibility Complex; Male; Middle Aged; Norepinephrine; Polymorphism, Single Nucleotide; Postoperative Complications; Tumor Necrosis Factor-alpha; Vascular Resistance; Vasoconstrictor Agents; Vasodilation | 2006 |